These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects]. Orzińska A; Guz K; Brojer E Ginekol Pol; 2009 Oct; 80(10):768-71. PubMed ID: 19943542 [TBL] [Abstract][Full Text] [Related]
23. [Comparison between genotyping and serological phenotyping in RhCE blood group]. Zhou HY; Zhang YZ; Meng QB; Bai XH; Wang CR; Cao Q; Lan JC Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):66-9. PubMed ID: 18247308 [TBL] [Abstract][Full Text] [Related]
24. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood. Sekizawa A; Watanabe A; Kimura T; Saito H; Yanaihara T; Sato T Obstet Gynecol; 1996 Apr; 87(4):501-5. PubMed ID: 8602298 [TBL] [Abstract][Full Text] [Related]
25. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies. Spence WC; Maddalena A; Demers DB; Bick DP J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123 [TBL] [Abstract][Full Text] [Related]
26. The use of maternal plasma for prenatal RhD blood group genotyping. Finning K; Martin P; Daniels G Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110 [TBL] [Abstract][Full Text] [Related]
28. Fetal blood group genotyping: present and future. Daniels G; Finning K; Martin P; Summers J Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196 [TBL] [Abstract][Full Text] [Related]
29. Hemolytic disease of the fetus and newborn in the molecular era. Fasano RM Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360 [TBL] [Abstract][Full Text] [Related]
30. Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw. Reiner AP; Teramura G; Aramaki KM Am J Perinatol; 1999; 16(6):277-81. PubMed ID: 10586980 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus. Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548 [TBL] [Abstract][Full Text] [Related]
32. Prenatal determination of fetal rhesus D status by DNA amplification of peripheral blood of rhesus-negative mothers. Lo YM; Bowell PJ; Selinger M; Mackenzie IZ; Chamberlain P; Gillmer MD; Elliott P; Pratt G; Littlewood TJ; Fleming KA Ann N Y Acad Sci; 1994 Sep; 731():229-36. PubMed ID: 7944125 [TBL] [Abstract][Full Text] [Related]
33. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138 [TBL] [Abstract][Full Text] [Related]
34. Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care. Clausen FB Prenat Diagn; 2014 May; 34(5):409-15. PubMed ID: 24431264 [TBL] [Abstract][Full Text] [Related]
35. [Prenatal typing of Rh- and Kell- blood group system antigens]. Faas BH; Maaskant-van Wijk PA; Beuling EA; Overbeeke MA; van der Schoot CE; Christiaens GC Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1804-7. PubMed ID: 10526582 [TBL] [Abstract][Full Text] [Related]
36. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766 [TBL] [Abstract][Full Text] [Related]
37. Confirmed non-invasive prenatal testing for foetal Rh blood group genotyping along with bi-allelic short insertion/deletion polymorphisms as a positive internal control. Armstrong-Fisher S; Koushki K; Mashayekhi K; Urbaniak SJ; van der Schoot E; Varzi AM Transfus Med; 2022 Apr; 32(2):141-152. PubMed ID: 35261100 [TBL] [Abstract][Full Text] [Related]
38. Single-cell analysis of the RhD blood type for use in preimplantation diagnosis in the prevention of severe hemolytic disease of the newborn. Van den Veyver IB; Chong SS; Cota J; Bennett PR; Fisk NM; Handyside AH; Cartron JP; Le Van Kim C; Colin Y; Snabes MC Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 1):533-40. PubMed ID: 7856682 [TBL] [Abstract][Full Text] [Related]
39. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707 [TBL] [Abstract][Full Text] [Related]
40. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]